We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
我们分析这笔39亿美元交易的隐藏风险：为何 Mizuho 下调 Select Medical 评级，以及股东面临什么。在锁定利润前了解详情。
